Elevance Health ( (ELV) ) has issued an announcement.
Elevance Health, Inc. announced that its officers will meet with investors to reaffirm the company’s earnings guidance for 2025, projecting earnings of $30.40 to $31.10 per diluted share, including net unfavorable items, and adjusted earnings of $34.15 to $34.85 per diluted share. The company also maintains its expectations for 2025 year-end total medical enrollment and Medicare Advantage membership, aligning with previous guidance. This announcement underscores Elevance Health’s commitment to transparency with its stakeholders and its strategic focus on maintaining stable enrollment figures and financial performance.
More about Elevance Health
Elevance Health, Inc. operates in the healthcare industry, providing a range of health insurance products and services. The company focuses on medical enrollment and Medicare Advantage membership, positioning itself as a significant player in the healthcare insurance market.
YTD Price Performance: 11.93%
Average Trading Volume: 1,665,781
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $93.09B
See more data about ELV stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com